Creative Biolabs offers Preclinical Trial-on-Chip Powered CAR-T Development Services to accelerate immunotherapy breakthroughs. These services address challenges such as high disease relapse rates, unpredictable clinical outcomes, and the limitations of non-physiologically relevant animal models. By using an organotypic immunocompetent microphysiological system, we replicate complex human bone marrow stroma and immune niches, enabling accurate predictions of therapeutic success or failure. This approach provides high-fidelity, human-relevant data to help optimize clinical decision-making and streamline your CAR-T development process.
Preclinical trial-on-chip systems recreate perfusable, three-dimensional human tumor microenvironments for functional immunotherapy testing. Recent microphysiological studies demonstrate improved prediction of immune-cell trafficking, efficacy, and resistance compared with conventional 2D culture and simplified animal models. These platforms enable real-time visualization and quantitative analysis of CAR-T behavior within human-relevant tissue architectures, supporting more reliable preclinical decision-making and translational confidence.
Creative Biolabs provides a transformative "clinical-trial-on-chip" platform that moves beyond static 2D assays to provide a dynamic, spatiotemporal evaluation of your CAR-T product. We deliver deep insights into T cell extravasation, tumor infiltration, and metabolic fitness within a human-relevant context.
Key problem-solving capabilities:
Discover How We Can Help - Request a Consultation to design a chip model that meets your specific research needs.
Our comprehensive service is designed to be a "plug-and-play" extension of your R&D department. The process is structured to provide high-resolution data at every biological milestone.
Final Deliverables: Clients receive a Comprehensive Functional Index Report including spatiotemporal killing kinetics, a Secretomic Profile Map of pro-inflammatory and regulatory cytokines, and High-Resolution Video Data of cell CAR-T/tumor interactions.
Creative Biolabs offers comprehensive preclinical trial-on-chip infrastructure and model development services. We engineer vascularized, patient-relevant microphysiological systems to replicate human tissue architecture, enabling accurate drug efficacy and safety evaluation while overcoming limitations of traditional in vitro and animal models.
Learn More →Creative Biolabs provides dynamic CAR-T efficacy validation services, using advanced microphysiological and tumor-on-chip models to assess CAR-T activity, persistence, and cytotoxicity, improving translational relevance and accelerating preclinical development.
Learn More →Creative Biolabs provides safety and toxicity forecasting services with advanced organ-on-chip and microphysiological platforms, allowing accurate prediction of adverse effects and enhancing translational confidence for drug development.
Learn More →Q1. How does the chip-based model compare to traditional mouse models?
A1. Mouse models are often immunodeficient or differ significantly from human immunity. Our humanized chip provides results and allows for real-time, in situ monitoring of human stroma-immune interactions that are impossible to visualize in vivo.
Q2. Can we use patient-derived samples on your platform?
A2. Yes. Our system is designed for both healthy donors and patient-specific autologous studies. We can prepare the chip with patient-derived bone marrow mononuclear cells to evaluate matched CAR-T responses.
Q3. What specific cytokines are measured during the screening?
A3. We measure a comprehensive panel of over 40 cytokines classified into effector, stimulatory, chemoattractive, and proinflammatory categories.
Q4. Is the vascular network in the chip actually perfusable?
A4. Absolutely. We utilize de novo vascularization where vascular cells self-assemble into a perfusable network under guidance from growth factors, mimicking the central sinus of the bone marrow.
Our Preclinical Trial-on-Chip Powered CAR-T Development Services help you de-risk and accelerate CAR-T development through vascularized, human-relevant microphysiological models that enable dynamic immune-tumor interaction analysis, real-time functional readouts, and data-driven CAR design optimization. Creative Biolabs is dedicated to providing high-fidelity, humanized preclinical platforms to de-risk your immunotherapy pipeline. Our Preclinical Trial-on-Chip Powered CAR-T Development Services offer the speed of in vitro assays with the biological complexity of in vivo models.
For detailed project discussions or technical specifications, please contact our team. Our team of specialists is ready to help you optimize your CAR-T development.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION